摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-chloro-2-methyl-3-phenylquinazolin-4(3H)-one | 4248-11-7

中文名称
——
中文别名
——
英文名称
6-chloro-2-methyl-3-phenylquinazolin-4(3H)-one
英文别名
6-chloro-2-methyl-3-phenylquinazolin-4-one
6-chloro-2-methyl-3-phenylquinazolin-4(3H)-one化学式
CAS
4248-11-7
化学式
C15H11ClN2O
mdl
——
分子量
270.718
InChiKey
XTXTZHNSUAYCLD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    181-182 °C
  • 沸点:
    436.8±47.0 °C(Predicted)
  • 密度:
    1.29±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    19
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    32.7
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    6-chloro-2-methyl-3-phenylquinazolin-4(3H)-onetris-(dibenzylideneacetone)dipalladium(0)三叔丁基膦N-甲基二环己基胺盐酸羟胺 、 potassium hydroxide 作用下, 以 甲醇正己烷甲苯 为溶剂, 反应 50.0h, 生成 N-hydroxy-3-(2-methyl-4-oxo-3-phenyl-3,4-dihydro-quinazolin-6-yl)acrylamide
    参考文献:
    名称:
    Quinazolin-4-one Derivatives as Selective Histone Deacetylase-6 Inhibitors for the Treatment of Alzheimer’s Disease
    摘要:
    Novel quinazolin-4-one derivatives containing a hydroxamic acid moiety were designed and synthesized. All compounds were subjected to histone deacetylase (HDAC) enzymatic assays to identify selective HDAC6 inhibitors with nanomolar IC50 values. (E)-3-(2-Ethyl-7-fluoro-4-oxo-3-phenethyl-3,4-dihydroquinazolin-6-yl)-N-hydroxyacrylamide, 4h, NHis the most potent HDAC6 inhibitor (IC50, 8 nM). In vitro, these compounds induced neurite outgrowth accompanied by growth-associated protein 43 expression, and they enhanced the synaptic activities of PC12 and SH-SY5Y neuronal cells without producing toxic or mitogenic effects. Several of the compounds dramatically increased nonhistone protein acetylation, specifically of g-tubulin. Some of the more potent HDAC6 inhibitors decreased zinc-mediated beta-amyloid aggregation in vitro. N-Hydroxy-3-(2-methyl-4-oxo-3-phenethyl-3,4-dihydroquinazolin-7-yl)-acrylarnide, 3f, the most promising drug candidate, selectively inhibits HDAC6 (IC50,29 nM), practically does not affect human ether-a-go-go-related membrane channel activity (IC50 >10 mu M) or cytochrome P450 activity (IC50 >63 mu M) in vitro, and significantly improves learning-based performances of mice with beta-amyloid-induced hippocampal lesions.
    DOI:
    10.1021/jm400564j
  • 作为产物:
    描述:
    6-chloro-2-methyl-3-phenyl-2,3-dihydro-1H-quinazolin-4-one 在 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下, 以 氯仿 为溶剂, 反应 1.0h, 以38.9 mg的产率得到6-chloro-2-methyl-3-phenylquinazolin-4(3H)-one
    参考文献:
    名称:
    铜催化 2-氨基苯甲酰胺与叔胺串联反应合成喹唑啉酮衍生物
    摘要:
    我们开发了铜催化的 2-氨基苯甲酰胺与叔胺的串联反应,用于形成喹唑啉酮衍生物。该策略包括在一锅中进行的两个步骤(环化和偶联)。许多底物在标准条件下反应良好,以中等至良好的产率得到相应的喹唑啉酮衍生物。
    DOI:
    10.1055/s-0036-1588881
点击查看最新优质反应信息

文献信息

  • Convenient synthesis of 2,3-disubstituted quinazolin-4(3H)-ones and 2-styryl-3-substituted quinazolin-4(3H)-ones: applications towards the synthesis of drugs
    作者:Dinesh Kumar、Pradeep S. Jadhavar、Manesh Nautiyal、Himanshu Sharma、Prahlad K. Meena、Legesse Adane、Sahaj Pancholia、Asit K. Chakraborti
    DOI:10.1039/c5ra03888j
    日期:——

    Simple, convenient, and green synthetic protocols have been developed for the one pot synthesis of 2,3-disubstituted quinazolin-4(3H)-ones and 2-styryl-3-substituted quinazolin-4(3H)-ones under catalyst and solvent free conditions.

    已开发出简单、方便且绿色的合成方案,用于在无催化剂和溶剂的条件下一锅法合成2,3-二取代喹唑啉-4(3H)-酮和2-苯乙烯基-3-取代喹唑啉-4(3H)-酮。
  • Synthesis and Biological Evaluation of Quinazoline-4-thiones
    作者:Lenka Kubicová、Martin Šustr、Katarína Kráľová、Vladimír Chobot、Jitka Vytlačilová、Luděk Jahodář、Pia Vuorela、Miloš Macháček、Jarmila Kaustová
    DOI:10.3390/81100756
    日期:——
    Several 2,2-dimethyl-3-phenyl-1,2-dihydroquinazoline-4(3H)-thiones and 2-methyl-3-phenylquinazoline-4(3H)-thiones were synthesized and tested for their antimycobacterial, photosynthesis-inhibiting, and antialgal activity. Antimycobacterially active compounds were found among the 6-chloro substituted compounds. 6-Chloro-3-(4-isopropylphenyl)-2-methylquinazoline-4(3H)-thione exhibited higher activity than the isoniazid standard against Mycobacterium avium and M. kansasii. Most of the compounds possessed photosynthesis-inhibiting activity. 6-Chloro-2,2-dimethyl-3-phenyl-1,2-dihydroquinazoline-4(3H)-thione and its 3´-chloro- and 3´,4´-dichloro analogs were most effective in the inhibition of oxygen evolution rate in spinach chloroplasts. Of compounds selected for toxicological screening, 6-chloro-3-(4-isopropylphenyl)-2-methyl-quinazoline-4(3H)-thione was the only one active in the brine shrimp bioassay.
    合成了几种2,2-二甲基-3-苯基-1,2-二氢喹啉-4(3H)-硫酮和2-甲基-3-苯基喹啉-4(3H)-硫酮,并测试了它们的抗分枝杆菌、抑制光合作用和抗藻活性。在6-氯取代的化合物中发现了具有抗分枝杆菌活性的化合物。6-氯-3-(4-异丙基苯基)-2-甲基喹啉-4(3H)-硫酮对分枝杆菌avium和M. kansasii的活性高于异烟肼标准。大多数化合物具有抑制光合作用的活性。6-氯-2,2-二甲基-3-苯基-1,2-二氢喹啉-4(3H)-硫酮及其3'-氯和3',4'-二氯类似物在抑制菠菜叶绿体氧气释放速率方面最为有效。在选择的毒理筛选化合物中,6-氯-3-(4-异丙基苯基)-2-甲基喹啉-4(3H)-硫酮是唯一在咸水虾生物测定中活性的化合物。
  • HISTONE DEACETYLASES (HDACS) INHIBITORS
    申请人:ANNJI PHARMACEUTICAL CO., LTD.
    公开号:US20130267542A1
    公开(公告)日:2013-10-10
    Histone deacetylases inhibitors (HDACIs) and compositions comprising the same are disclosed. Methods of treating diseases and conditions wherein inhibition of HDAC provides a benefit are also disclosed.
    揭示了组蛋白去乙酰化酶抑制剂(HDACIs)和包含其的组合物。还公开了通过抑制HDAC来获益的治疗疾病和病况的方法。
  • Histone deacetylases (HDACs) inhibitors
    申请人:ANNJI PHARMACEUTICAL CO., LTD.
    公开号:US09155739B2
    公开(公告)日:2015-10-13
    Histone deacetylases inhibitors (HDACIs) and methods for treating cancer in a subject in need thereof are disclosed. The HDACIs comprise a compound of Formula X. or a pharmaceutically acceptable salt thereof. In one embodiment of the invention, R1 is ethyl; R2 is 2-phenylethyl; R3 is hydrogen; R4 is fluoro; R5 is (2E)-3-N-hydroxyamino-3-oxo-propenyl; and R6 is hydrogen, or a salt thereof. In another embodiment of the invention, R1 is ethyl; R2 is 2-phenylethyl; R3 is hydrogen; R4 is (2E)-3-N-hydroxyamino-3-oxo-propenyl; R5 is chloro or fluoro; and R6 is hydrogen.
    本发明揭示了组蛋白去乙酰化酶抑制剂(HDACIs)及其治疗需要的患者的癌症的方法。HDACIs包括化合物X的一个衍生物或其药学上可接受的盐。在本发明的一个实施例中,R1为乙基;R2为2-苯乙基;R3为氢;R4为氟;R5为(2E)-3-N-羟基氨基-3-氧代丙烯基;R6为氢,或其盐。在本发明的另一个实施例中,R1为乙基;R2为2-苯乙基;R3为氢;R4为(2E)-3-N-羟基氨基-3-氧代丙烯基;R5为氯或氟;R6为氢。
  • Metal‐Free, Photoredox‐Catalyzed Synthesis of Quinazolin‐4(3 <i>H</i> )‐ones and Benzo[4,5]imidazo[1,2‐ <i>c</i> ]quinazolines Using Trialkylamines as Alkyl Synthon
    作者:Ajithkumar Arumugam、Pushbaraj Palani、Mageshwari Anandan、Venkatramaiah Nutalapati、Gopal Chandru Senadi
    DOI:10.1002/ejoc.202300100
    日期:2023.3.21
    the construction of 2-alkyl substituted quinazolin-4(3H)-ones and benzo[4,5]imidazo[1,2-c]quinazolines using trialkylamines as carbon synthons has been developed. Some of the notable features of this methodology include the synthesis of potent central nervous system depressants (CNS) drug molecules methaqualone (3 la), mecloqualone (3 pa) and gram-scale synthesis.
    一种使用三烷基胺作为碳合成子构建 2-烷基取代喹唑啉-4(3 H )-酮和苯并[4,5]咪唑并[1,2-c]喹唑啉的无金属可见光光催化方法发达。该方法的一些显着特征包括强效中枢神经系统抑制剂 (CNS) 药物分子甲喹酮 ( 3 la )、甲氯喹酮 ( 3 pa ) 的合成和克级合成。
查看更多